Drug Information

Drug General Information
Drug ID
D0Y7WU
Former ID
DNC007228
Drug Name
6-(4-methoxyphenyl)-4-morpholino-2H-pyran-2-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528738]
Formula
C16H17NO4
Canonical SMILES
COC1=CC=C(C=C1)C2=CC(=CC(=O)O2)N3CCOCC3
InChI
1S/C16H17NO4/c1-19-14-4-2-12(3-5-14)15-10-13(11-16(18)21-15)17-6-8-20-9-7-17/h2-5,10-11H,6-9H2,1H3
InChIKey
PRPSUNXAZLZCBS-UHFFFAOYSA-N
PubChem Compound ID
21106426
Target and Pathway
Target(s) DNA-dependent protein kinase catalytic subunit Target Info Inhibitor [528738]
KEGG Pathway Non-homologous end-joining
Cell cycle
NetPath Pathway IL1 Signaling Pathway
Pathway Interaction Database DNA-PK pathway in nonhomologous end joining
Coregulation of Androgen receptor activity
Class I PI3K signaling events mediated by Akt
BARD1 signaling events
Reactome Nonhomologous End-Joining (NHEJ)
WikiPathways DNA Damage Response
Non-homologous end joining
FAS pathway and Stress induction of HSP regulation
Cytosolic sensors of pathogen-associated DNA
Retinoblastoma (RB) in Cancer
Prostate Cancer
Double-Strand Break Repair
Cell Cycle
miRNA Regulation of DNA Damage Response
References
Ref 528738J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.
Ref 528738J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.